Search Within

Edric Robinson

Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Center for Pancreatic Cancer Research (5)
  2. Department of Medicine (5)
  3. Gastrointestinal Oncology Service (5)
  4. Solid Tumor Oncology Division (5)
  5. Biostatistics Service (3)
  6. Epidemiology and Biostatistics (3)

More Groups

People
  1. David Kelsen (5)
  2. Manish Shah (5)
  3. Marinela Capanu (3)
  4. David Ilson (2)
  5. Elizabeth Smyth (2)
  6. Yelena Janjigian (2)

More People

Years
  1. 2011 (4)
  2. 2009 (1)
Publications
  1. Journal of Clinical Oncology (5)
Publishers
  1. American Society of Clinical Oncology (5)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Bevacizumab (Bev) plus chemotherapy for advanced gastroesophageal adenocarcinoma (GC): Combined U. S. experience
    Meeting Abstract

    Smyth, E. C.; Enzinger, P. C.; Li, J.; Vincitore, M.; Lacy, J.; El-Rayes, B. F.; Kunz, P. L.; Ford, J. M.; Robinson, E.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Prognostic significance of human epidermal growth factor-2 (HER2) in advanced gastric cancer: A US and European international collaborative analysis
    Meeting Abstract

    Shah, M. A.; Janjigian, Y. Y.; Pauligk, C.; Werner, D.; Kelsen, D. P.; Jaeger, E.; Altmannsberger, H.; Robinson, E.; Tang, L. H.; Barbashina, V. V.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)
    Meeting Abstract

    Smyth, E. C.; Janjigian, Y. Y.; Robinson, E.; Sheehy, E. C.; Karpenko, I.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of modified docetaxel, cisplatin, and fluorouracil with bevacizumab in patients with metastatic gastroesophageal adenocarcinoma
    Journal Article

    Shah, M. A.; Jhawer, M.; Ilson, D. H.; Lefkowitz, R. A.; Robinson, E.; Capanu, M.; Kelsen, D. P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Analysis of survival with modified docetaxel, cisplatin, fluorouracil (mDCF), and bevacizumab (BEV) in patients with metastatic gastroesophageal (GE) adenocarcinoma: Results of a phase II clinical trial
    Meeting Abstract

    Kelsen, D.; Jhawer, M.; Ilson, D.; Tse, A.; Randazzo, J.; Robinson, E.; Capanu, M.; Shah, M. A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save